Viewing Study NCT01322932

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2026-05-07 @ 7:34 AM
Study NCT ID: NCT01322932
Status: COMPLETED
Last Update Posted: 2015-12-22
First Post: 2011-03-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey
Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Medication Adherence View
None HIV Infection View
None efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [Substance Name] View
None efavirenz View
None emtricitabine View
None Patient Satisfaction View
None tenofovir disoproxil fumarate View